Dr. Fernando Martin Safdie, MD

Dr. Safdie practices at Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida.

Dr. Safdie's NPI, 1881956944, was assigned on June 13, 2012. Dr. Safdie graduated from University of Buenos Aires in 2007. Dr. Safdie holds Florida license TRN#15318.

Dr. Safdie's primary practice is Mount Sinai Medical Center, at 4300 Alton Rd, Miami Beach, FL 33140 in Miami-Dade County. The practice phone is (305) 674-2121.

Dr. Safdie's primary practice is Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida. The medical group on file is Mount Sinai Medical Center. Dmand AI also links Dr. Safdie to 1 more home health agency, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Safdie practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Safdie's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Safdie is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Safdie's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists esophagus, stomach, or upper small intestine surgery and lung resection among the conditions Dr. Safdie treats.

CMS data shows 379 Medicare services from Dr. Safdie across 11 procedure codes in 2024, for 129 Medicare patients. Medicare paid $39,535 for them.

CMS counts 129 Medicare patients who saw Dr. Safdie in 2024. The largest group is 75 to 84, with 56 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Safdie's median patient age at 73, with 47% women.

In 2024, Dr. Safdie wrote 69 Medicare Part D claims for 40 patients. 96% of them were for generic drugs. CMS names the drug for 22 of them, across 1 drug with 11 or more claims each, at $84 in total drug cost. In 2023, CMS named 42 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Safdie for performance year 2024, reported through an alternative payment model (APM). Dr. Safdie accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Safdie as offering telehealth. CMS counts 20 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Safdie, more than 50% of the clinicians it reports for that procedure.

Dmand AI links 17 papers to Dr. Safdie, published from 2008 to 2025. 2012 was the busiest year, with 2. The most frequent topics are Antineoplastic Agents, Fasting and Cell Line, Tumor. Dr. Safdie's most frequent co-authors are Jessica Emilia Wahi, Raul Jacobo Rosenthal, MD and Hisham Bahmad.

CMS Open Payments shows 170 general payments to Dr. Safdie from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 46% of the total. Intuitive Surgical, Inc. paid the most, $14,491.

Dr. Safdie graduated from University of Buenos Aires in 2007.

Dr. Safdie is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.